1,555 research outputs found
Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
In recent years, tyrosine kinases (TKs) have been recognized as central players and regulators of cancer cell proliferation, apoptosis, and angiogenesis, and are therefore considered suitable potential targets for anti-cancer therapies. Several strategies for targeting TKs have been developed, the most successful being monoclonal antibodies and small molecule tyrosine kinase inhibitors. However, increasing evidence of acquired resistance to these drugs has been documented, and extensive preclinical studies are ongoing to try to understand the molecular mechanisms by which cancer cells are able to bypass their inhibitory activity. This review intends to present the most recently identified molecular mechanisms that mediate acquired resistance to tyrosine kinase inhibitors, identified through the use of in vitro models or the analysis of patient samples. The knowledge obtained from these studies will help to design better therapies that prevent and overcome resistance to treatment in cancer patients
Electron Drift Velocities In N2, CO2, And (N 2+CO2) Laser Mixtures
A time-of-flight technique has been used to obtain electron drift velocities in N2, CO2, and N2-CO2 mixtures covering the E/N range 3-93 Td. In the case of the pure gases, excellent agreement with previous work is obtained over the entire E/N range. The mixtures, which are of laser importance, have not been studied previously
Use of concentrated bone marrow aspirate and platelet rich plasma during minimally invasive decompression of the femoral head in the treatment of osteonecrosis
ABSTRACT The aim of this paper is to describe our surgical
procedure for the treatment of osteonecrosis of the femoral
head using a minimally invasive technique. We have
limited the use of this procedure for patients with pre-collapse
osteonecrosis of the femoral head (Ficat Stage I or II).
To treat osteonecrosis of the femoral head at our institution
we currently use a combination of outpatient, minimally
invasive iliac crest bone marrow aspirations and blood
draw combined with decompressions of the femoral head.
Following the decompression of the femoral head, adult
mesenchymal stem cells obtained from the iliac crest and
platelet rich plasma are injected into the area of osteonecrosis.
Patients are then discharged from the hospital using
crutches to assist with ambulation. This novel technique
was utilized on 77 hips. Sixteen hips (21%) progressed to
further stages of osteonecrosis, ultimately requiring total
hip replacement. Significant pain relief was reported in
86% of patients (n = 60), while the rest of patients reported
little or no pain relief. There were no significant complications
in any patient. We found that the use of a minimally
invasive decompression augmented with concentrated
bone marrow and platelet rich plasma resulted in significant
pain relief and halted the progression of disease in a
majority of patient
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition
<p>Abstract</p> <p>Background</p> <p>Gastric cancer is the second leading cause of cancer mortality in the world. The receptor tyrosine kinase MET is constitutively activated in many gastric cancers and its expression is strictly required for survival of some gastric cancer cells. Thus, MET is considered a good candidate for targeted therapeutic intervention in this type of tumor, and MET inhibitors recently entered clinical trials. One of the major problems of therapies targeting tyrosine kinases is that many tumors are not responsive to treatment or eventually develop resistance to the drugs. Perspective studies are thus mandatory to identify the molecular mechanisms that could cause resistance to these therapies.</p> <p>Results</p> <p>Our <it>in vitro </it>and <it>in vivo </it>results demonstrate that, in MET-addicted gastric cancer cells, the activation of HER (Human Epidermal Receptor) family members induces resistance to MET silencing or inhibition by PHA-665752 (a selective kinase inhibitor). We provide molecular evidences highlighting the role of EGFR, HER3, and downstream signaling pathways common to MET and HER family in resistance to MET inhibitors. Moreover, we show that an <it>in vitro </it>generated gastric cancer cell line resistant to MET-inhibition displays overexpression of HER family members, whose activation contributes to maintenance of resistance.</p> <p>Conclusions</p> <p>Our findings predict that gastric cancer tumors bearing constitutive activation of HER family members are poorly responsive to MET inhibition, even if this receptor is constitutively active. Moreover, the appearance of these alterations might also be responsible for the onset of resistance in initially responsive tumors.</p
Modeling Pathogenic Mutations of Human Twinkle in Drosophila Suggests an Apoptosis Role in Response to Mitochondrial Defects
The human gene C10orf2 encodes the mitochondrial replicative DNA helicase Twinkle, mutations of which are responsible for a significant fraction of cases of autosomal dominant progressive external ophthalmoplegia (adPEO), a human mitochondrial disease caused by defects in intergenomic communication. We report the analysis of orthologous mutations in the Drosophila melanogaster mitochondrial DNA (mtDNA) helicase gene, d-mtDNA helicase. Increased expression of wild type d-mtDNA helicase using the UAS-GAL4 system leads to an increase in mtDNA copy number throughout adult life without any noteworthy phenotype, whereas overexpression of d-mtDNA helicase containing the K388A mutation in the helicase active site results in a severe depletion of mtDNA and a lethal phenotype. Overexpression of two d-mtDNA helicase variants equivalent to two human adPEO mutations shows differential effects. The A442P mutation exhibits a dominant negative effect similar to that of the active site mutant. In contrast, overexpression of d-mtDNA helicase containing the W441C mutation results in a slight decrease in mtDNA copy number during the third instar larval stage, and a moderate decrease in life span in the adult population. Overexpression of d-mtDNA helicase containing either the K388A or A442P mutations causes a mitochondrial oxidative phosphorylation (OXPHOS) defect that significantly reduces cell proliferation. The mitochondrial impairment caused by these mutations promotes apoptosis, arguing that mitochondria regulate programmed cell death in Drosophila. Our study of d-mtDNA helicase overexpression provides a tractable Drosophila model for understanding the cellular and molecular effects of human adPEO mutations
HAp Nanofibers Grown with Crystalline Preferential Orientation and Its Influence in Mechanical Properties of Organic-Inorganic Composite Materials
There are several synthesis techniques to obtain hydroxyapatite (HAp). Some use surfactant agents, amino acids or halogen salts to control structural nucleation and crystal growth. In others, the use of hydrothermal process to carry out the reaction is effective for HAp synthesis. Microwave-assisted hydrothermal method (MAHM) has been successfully applied in the synthesis of HAp nanostructures, which present well-defined morphologies, high crystallinity and high purity. This is important because nano-HAp is attracting interest as a biomaterial for use in prosthetic applications due to its similarity in size, crystallinity and chemical composition with human hard tissue. In this chapter, developments in obtaining HAp nanofibers, with a crystal growth with preferential orientation, as well as morphology control achieved by using the MAHM is discussed. Also, the synthesized fibers were used to cast ceramics with controlled and interconnected porosity through the modified gelcasting process. Then, these HAp ceramics were impregnated with a water solution of gelatin in order to obtain an organic-inorganic composite material, similar to natural bone tissue. The maximum compressive strengths were determined and the composite materials showed mechanical properties that make them suitable to be used as bone tissue implants
- …